Nashaat Tawfik, MBA, B.Sc., a pharmacist from Saudi Arabia, has been awarded National Board Certification by the American Association of Bariatric Counselors (AABC). After completing a specialized fellowship training and education program in bariatric science he was recently credentialed as a Board Certified Bariatric Educator (CBE).
Nashaat earned his Masters of Business Administration at Leicester University in England and his Bachelor of Pharmaceutical Science at Cairo University in Egypt. He has also been certified by The World Obesity Federation after completing their Strategic Centre for Obesity Education (SCOPE) program.
Currently he serves as the Obesity Business Director for Novo Nordisk in SA. He has been instrumental in the professional marketing of the novel anti-obesity pharmaceutical, Saxenda. In addition, at Novartis Pharma he headed up the Cardio Metabolic Business Unit in SA. In this capacity he helped market pharmaceuticals that targeted many of the diseases associated with obesity (heart disease, hypertension and diabetes). As an educator he has conducted many obesity management programs for health professionals as well as community health programs for the public.
In recognition of his pharmacology expertise, intense interest in obesity treatment and prevention and commitment to public health education, AABC awarded him a fellowship and he has been recently Board Certified and Credentialed as a Certified Bariatric Educator (CBE). He will further the AABC global mission of providing best practices in the care, treatment and prevention of obesity and related diseases.